Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
NAPCO Security Technologies, Inc. (NSSC) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Rigel Pharmaceuticals, Inc. (RIGL) - free report >>
NAPCO Security Technologies, Inc. (NSSC) - free report >>
Image: Bigstock
New Strong Buy Stocks for November 28th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Aquestive Therapeutics, Inc. (AQST - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 72% over the last 60 days.
Aquestive Therapeutics, Inc. Price and Consensus
Aquestive Therapeutics, Inc. price-consensus-chart | Aquestive Therapeutics, Inc. Quote
Dutch Bros Inc. (BROS - Free Report) : This drive-thru franchise company has seen the Zacks Consensus Estimate for its current year earnings increasing 40% over the last 60 days.
Dutch Bros Inc. Price and Consensus
Dutch Bros Inc. price-consensus-chart | Dutch Bros Inc. Quote
Napco Security Technologies, Inc. (NSSC - Free Report) : This electronic security company has seen the Zacks Consensus Estimate for its current year earnings increasing 12% over the last 60 days.
NAPCO Security Technologies, Inc. Price and Consensus
NAPCO Security Technologies, Inc. price-consensus-chart | NAPCO Security Technologies, Inc. Quote
Rigel Pharmaceuticals, Inc. (RIGL - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 26.9% over the last 60 days.
Rigel Pharmaceuticals, Inc. Price and Consensus
Rigel Pharmaceuticals, Inc. price-consensus-chart | Rigel Pharmaceuticals, Inc. Quote
Rubicon Technologies, Inc. : This cloud-based waste and recycling solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 69% over the last 60 days.
Rubicon Technologies, Inc. Price and Consensus
Rubicon Technologies, Inc. price-consensus-chart | Rubicon Technologies, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.